A transcription factor has been identified to be the main factor responsible for the tendency of glioblastoma stem cells to form tumours. A group of researchers, guided by Professor Fang Zhiyou and...
The Phase I dose-escalation study (called “IPAX-2”) will evaluate TLX101 in combination with post-surgical standard of care comprised of external beam radiation therapy (EBRT) and temozolomide in...
Cure Brain Cancer Foundation is Australia’s leading organisation for brain cancer research, advocacy, and awareness. Find out how this not-for-profit is collaborating with researchers and industry...
A multi-disciplinary team comprising researchers from the National Neuroscience Institute, National University of Singapore and the Duke-NUS Medical School has recently been awarded the Large...
In this article, Dr Daniel Tan introduces Tumour Treating Fields, a promising therapy for patients with glioblastoma multiforme. Glioblastoma multiforme or GBM is a feared, lethal and aggressive...
Study by the University of Pennsylvania demonstrates the benefits of imaging to identify suitability of liquid biopsy of glioblastoma patients. About 12,000 Americans are diagnosed with glioblastoma...
Researchers from Northwestern University apply for FDA approval of novel treatment for patients with recurrent glioblastoma. The anatomical structure of the brain poses various challenges in drug...
The team discovered a method to temporarily weaken the blood-brain barrier, allowing selected chemotherapy drugs to enter parts of the brain. A research group led by Dr. Patrick Hsieh of the...
